Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during Toxoplasma gondii infection.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMC 3382309)

Published in J Leukoc Biol on April 09, 2012

Authors

David B Chou1, Brian Sworder, Nicolas Bouladoux, Cindy N Roy, Amiko M Uchida, Michael Grigg, Pamela G Robey, Yasmine Belkaid

Author Affiliations

1: Mucosal Immunology, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Articles citing this

Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell (2014) 3.13

IL-6 as a keystone cytokine in health and disease. Nat Immunol (2015) 2.14

Immune response and immunopathology during toxoplasmosis. Semin Immunopathol (2012) 1.38

Regulation of hematopoietic and leukemic stem cells by the immune system. Cell Death Differ (2014) 1.10

Dual role for inflammasome sensors NLRP1 and NLRP3 in murine resistance to Toxoplasma gondii. MBio (2014) 1.09

Bone marrow stromal cell assays: in vitro and in vivo. Methods Mol Biol (2014) 0.95

Host immune response to infection and cancer: unexpected commonalities. Cell Host Microbe (2014) 0.88

A Hitchhiker's Guide to Myeloid Cell Subsets: Practical Implementation of a Novel Mononuclear Phagocyte Classification System. Front Immunol (2015) 0.85

G-CSF drives a posttraumatic immune program that protects the host from infection. J Immunol (2014) 0.83

Infection-induced changes in hematopoiesis. J Immunol (2014) 0.83

Deficiency of lipid phosphatase SHIP enables long-term reconstitution of hematopoietic inductive bone marrow microenvironment. Dev Cell (2013) 0.80

Selected cytokine pathways in rheumatoid arthritis. Semin Immunopathol (2017) 0.80

Disruption of bone and skeletal muscle in severe burns. Bone Res (2015) 0.77

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality? Int J Mol Sci (2016) 0.76

The Role of the Bone Marrow Stromal Compartment in the Hematopoietic Response to Microbial Infections. Front Immunol (2017) 0.75

"Mesenchymal stem cells": fact or fiction, and implications in their therapeutic use. F1000Res (2017) 0.75

Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications. Stem Cells Int (2017) 0.75

Articles cited by this

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature (2010) 15.28

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest (2004) 11.05

Anemia of chronic disease. N Engl J Med (2005) 10.88

Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell (2007) 10.13

Interleukin-6 and the acute phase response. Biochem J (1990) 7.97

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood (2008) 7.15

Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell (2008) 6.26

Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity (2006) 5.98

Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. Cell Stem Cell (2007) 5.28

Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity (2009) 4.85

Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity (2008) 4.07

Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med (2009) 4.03

Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity (2011) 3.88

CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J Immunol (2007) 3.39

Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med (1996) 2.97

Hepcidin and disorders of iron metabolism. Annu Rev Med (2011) 2.67

Ontogeny of the hematopoietic system. Annu Rev Immunol (2007) 2.55

Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest (2004) 2.25

Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J Exp Med (1997) 1.93

IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens. J Immunol (1995) 1.76

An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice. Nat Genet (2004) 1.68

Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin. J Clin Oncol (2010) 1.66

Immunization and infection change the number of recombination activating gene (RAG)-expressing B cells in the periphery by altering immature lymphocyte production. J Exp Med (2000) 1.57

Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood (2010) 1.56

Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion. J Leukoc Biol (2007) 1.47

Fibrin-mediated protection against infection-stimulated immunopathology. J Exp Med (2003) 1.43

Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med (2011) 1.43

IL-1R type I-dependent hemopoietic stem cell proliferation is necessary for inflammatory granulopoiesis and reactive neutrophilia. J Immunol (2009) 1.39

Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice. Infect Immun (1997) 1.34

Anemia of inflammation. Hematology Am Soc Hematol Educ Program (2010) 1.32

Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions. Stem Cell Res (2008) 1.27

Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone (2003) 1.19

The value of blocking IL-6 outside of rheumatoid arthritis: current perspective. Curr Opin Rheumatol (2011) 1.17

Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals. Blood (2009) 1.17

A protective role for IL-6 during early infection with Toxoplasma gondii. Parasite Immunol (1998) 1.10

Hepcidin and cytokines in anaemia. Hematology (2005) 0.98

Isolation of the stromal-vascular fraction of mouse bone marrow markedly enhances the yield of clonogenic stromal progenitors. Blood (2012) 0.97

Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway. PLoS One (2010) 0.95

Vascular cell adhesion molecule 1-positive reticular cells express interleukin-7 and stem cell factor in the bone marrow. Blood (1995) 0.94

Globin gene silencing in primary erythroid cultures. An inhibitory role for interleukin-6. J Biol Chem (1997) 0.86

Articles by these authors

A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med (2007) 15.17

Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med (2007) 11.82

Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol (2010) 9.72

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med (2008) 8.79

A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med (2011) 8.26

Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature (2010) 7.50

Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity (2008) 5.82

Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science (2013) 5.09

Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity (2009) 4.85

The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med (2013) 4.32

Compartmentalized control of skin immunity by resident commensals. Science (2012) 4.19

Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood (2002) 3.93

Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity (2008) 3.25

Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med (2006) 3.22

The role of retinoic acid in tolerance and immunity. Immunity (2011) 3.16

Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science (2014) 3.13

Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha. Immunity (2011) 3.06

CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J Exp Med (2005) 3.03

Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat Immunol (2004) 2.86

Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol (2005) 2.85

A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J Immunol (2005) 2.81

Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol (2002) 2.61

Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity (2013) 2.61

Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med (2004) 2.57

Signaling via the IL-20 receptor inhibits cutaneous production of IL-1β and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus. Nat Immunol (2013) 2.55

Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway. J Exp Med (2010) 2.54

The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology. Immunity (2012) 2.52

The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol (2004) 2.50

Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Genet (2003) 2.43

GATA3 controls Foxp3⁺ regulatory T cell fate during inflammation in mice. J Clin Invest (2011) 2.43

C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity (2005) 2.24

Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. J Clin Invest (2010) 2.18

Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science (2012) 2.01

IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog (2008) 2.01

BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain. Proc Natl Acad Sci U S A (2012) 1.93

CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J Exp Med (2006) 1.88

Modulation of canonical Wnt signaling by the extracellular matrix component biglycan. Proc Natl Acad Sci U S A (2011) 1.85

Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J Biol Chem (2005) 1.82

Skeletal site-specific characterization of orofacial and iliac crest human bone marrow stromal cells in same individuals. Bone (2006) 1.81

Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice. J Immunol (2007) 1.78

CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis (2006) 1.77

Mice deficient in LRG-47 display increased susceptibility to mycobacterial infection associated with the induction of lymphopenia. J Immunol (2004) 1.76

Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency. Cytotherapy (2011) 1.73

T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature (2008) 1.68

Wnt/β-catenin signaling is differentially regulated by Gα proteins and contributes to fibrous dysplasia. Proc Natl Acad Sci U S A (2011) 1.62

Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood (2011) 1.61

Distinct requirements for T-bet in gut innate lymphoid cells. J Exp Med (2012) 1.61

Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J Exp Med (2006) 1.59

A genome-wide association analysis of serum iron concentrations. Blood (2009) 1.55

Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation. J Immunol (2006) 1.53

Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection. J Infect Dis (2007) 1.53

Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J Immunol (2010) 1.53

Exercise-induced changes in the cortical bone of growing mice are bone- and gender-specific. Bone (2007) 1.52

Normal vision despite narrowing of the optic canal in fibrous dysplasia. N Engl J Med (2002) 1.47

The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46

In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy. Stem Cells (2008) 1.41

Serum antioxidants and inflammation predict red cell distribution width in older women: the Women's Health and Aging Study I. Clin Nutr (2010) 1.39

Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome. J Bone Miner Res (2003) 1.39

Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab (2003) 1.36

The establishment of a bank of stored clinical bone marrow stromal cell products. J Transl Med (2012) 1.34

Parathyroid-specific double knockout of Gq and G11 alpha-subunits leads to a phenotype resembling germline knockout of the extracellular Ca2+ -sensing receptor. Mol Endocrinol (2006) 1.31

Genotyping of Toxoplasma gondii by multiplex PCR and peptide-based serological testing of samples from infants in Poland diagnosed with congenital toxoplasmosis. J Clin Microbiol (2006) 1.31

Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection. Nat Med (2013) 1.30

Regulation of stem cell therapies under attack in Europe: for whom the bell tolls. EMBO J (2013) 1.28

Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions. Stem Cell Res (2008) 1.27

Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice. J Exp Med (2003) 1.26

Long-term outcome of optic nerve encasement and optic nerve decompression in patients with fibrous dysplasia: risk factors for blindness and safety of observation. Neurosurgery (2006) 1.23

Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection. Infect Immun (2005) 1.23

Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. J Immunol (2011) 1.23

Fibrous dysplasia in the spine: prevalence of lesions and association with scoliosis. J Bone Joint Surg Am (2004) 1.23

Association of CTLA4 polymorphism with regulatory T cell frequency. Eur J Immunol (2005) 1.22

Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. J Bone Miner Res (2007) 1.22

Optimization of DNA vaccination against cutaneous leishmaniasis. Vaccine (2002) 1.22

Intestinal microbiota: shaping local and systemic immune responses. Semin Immunol (2011) 1.21

Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability. Infect Immun (2003) 1.20

Superparamagnetic iron oxide nanoparticles labeling of bone marrow stromal (mesenchymal) cells does not affect their "stemness". PLoS One (2010) 1.20

A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone. J Clin Endocrinol Metab (2014) 1.20

Stem cells in the face: tooth regeneration and beyond. Cell Stem Cell (2012) 1.18

Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells. J Exp Med (2014) 1.16

IL-10 and TGF-beta control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice. J Immunol (2008) 1.16

In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages. PLoS One (2009) 1.12

miR-182 and miR-10a are key regulators of Treg specialisation and stability during Schistosome and Leishmania-associated inflammation. PLoS Pathog (2013) 1.11

Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant. Eur J Immunol (2002) 1.10

The mechanical phenotype of biglycan-deficient mice is bone- and gender-specific. Bone (2006) 1.09

Cytotoxicity mediated by the Fas ligand (FasL)-activated apoptotic pathway in stem cells. J Biol Chem (2009) 1.08

Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. Cell Host Microbe (2013) 1.08